Clinical trial
A Pilot Study of Recombinant Human Relaxin (rhRlx) in Compensated Congestive…
NCT00259116 · Corthera, Inc.(formerly BAS Medical, Inc.), a member of the Novartis group of companies, Industry · Completed
Key facts
| NCT number | NCT00259116 |
|---|---|
| Title | A Pilot Study of Recombinant Human Relaxin (rhRlx) in Compensated Congestive Heart Failure |
| Official title | A Pilot Safety and Dose-Finding Trial of Intravenous Recombinant Human Relaxin (rhRlx) in Compensated Congestive Heart Failure |
| Lead sponsor | Corthera, Inc.(formerly BAS Medical, Inc.), a member of the Novartis group of companies, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Heart Failure, Congestive |
| Intervention type | Drug |
| Interventions | Relaxin |
| Enrollment | 18 |
| Start date | Nov 1, 2005 |
| First posted | Nov 29, 2005 |
| Last update posted | Apr 15, 2009 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: